Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02465034 · ClinicalTrials.gov registry record · NA
Noninvasive Brain Stimulation to Evaluate Neural Plasticity After Stroke
A NA study, sponsored by Emory University.
- Terminated
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT02465034: Clinical Trial NA study, sponsored by Emory University.
NCT02465034 is a NA study that was terminated before completion, run by Emory University. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02465034, a NA study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to examine how different areas in the brain interact with each other and how using brain imaging and brain stimulation approaches can influence these interactions.
Primary Outcome
Long-term potentiation-like plasticity was measured using paired associative stimulation (PAS). PAS consists of repeated peripheral electric stimulation paired with Transcranial Magnetic Stimulation (TMS) applied to the motor cortex at varying interstimulus intervals. Participants received 180 paired stimuli at 0.25 hertz (Hz) for 12 minutes. Impaired long-term potentiation-like plasticity points towards reduced excitatory synaptic connectivity and deficits in sensorimotor integration. Decrease
Interventions
- DEVICE Transcranial Magnetic Stimulation
- DEVICE Traditional Paired Associative Stimulation
- DEVICE Median Nerve Stimulation
- DEVICE Corticocortical Paired Associative Stimulation
- DEVICE Sham Paired Associative Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2015-05 |
| Est. Completion | 2019-07-24 |
| Phase | NA |
Why NCT02465034 stopped before completion
NCT02465034 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 5 interventions - of which Transcranial Magnetic Stimulation is the first listed.
NCT02465034 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02465034 about?
NCT02465034 is a clinical study titled "Noninvasive Brain Stimulation to Evaluate Neural Plasticity After Stroke". The purpose of this study is to examine how different areas in the brain interact with each other and how using brain imaging and brain stimulation approaches can influence these interactions.
What is the current status of trial NCT02465034?
This trial is currently terminated. It is a NA study. The enrollment target is 45 participants. The study started on 2015-05. Estimated completion is 2019-07-24.
What interventions are being tested in trial NCT02465034?
The interventions under investigation include: Transcranial Magnetic Stimulation (DEVICE), Traditional Paired Associative Stimulation (DEVICE), Median Nerve Stimulation (DEVICE), Corticocortical Paired Associative Stimulation (DEVICE), Sham Paired Associative Stimulation (DEVICE).
Who is sponsoring clinical trial NCT02465034?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02465034's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia